Ascendis Pharma(ASND)
Search documents
Ascendis Pharma(ASND) - 2022 Q1 - Earnings Call Transcript
2022-05-12 03:29
Ascendis Pharma A/S (ASND) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Jan Mikkelsen – President and Chief Executive Officer Scott T. Smith – Senior Vice President and Chief Financial Officer Timothy J. Lee – Senior Director of Investment Officer Dr. Dana Pizzuti – Head of Development Operations and Chief Medical Officer Dr. Stina Singel – Senior Vice President, Head of Clinical Development, Oncology Conference Call Participants Jessica Fye – JPMorgan Josh Schimmer – Everco ...
Ascendis Pharma(ASND) - 2021 Q3 - Earnings Call Transcript
2021-11-11 05:13
Ascendis Pharma A/S (ASND) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Scott Smith - Senior Vice President and CFO Jan Mikkelsen - President and CEO Jesper Hoiland - Global Chief Commercial Officer Dr. Dana Pizzuti - Head, Development Operations and CMO Dr. Juha Punnonen - Head, Oncology Conference Call Participants Jessica Fye - J.P. Morgan Michelle Gilson - Canaccord Genuity Josh Schimmer - Evercore Alethia Young - Cantor Joori Park - SVB Leerink Operator Good day an ...
Ascendis Pharma(ASND) - 2020 Q4 - Annual Report
2021-03-09 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ OR ☐ SHELL COMPANY REPORT P ...
Ascendis Pharma(ASND) - 2020 Q3 - Earnings Call Transcript
2020-11-12 04:56
Ascendis Pharma A/S (ASND) Q3 2020 Earnings Conference Call November 11, 2020 4:30 PM ET Company Participants Scott Smith – Senior Vice President and Chief Financial Officer Jan Mikkelsen – President and Chief Executive Officer Mark Bach – Head-Clinical Development and Medical Affairs for Endocrinology Rare Diseases Jesper Høiland – Global Chief Commercial Officer Dana Pizzuti – Head-Development Operations Conference Call Participants Jessica Fye – JPMorgan Michelle Gilson – Canaccord Genuity Andrew Anido – ...